Latest Articles
Merck's ADC candidate meets goals in endometrial cancer study - MSN
Merck's ADC candidate meets goals in endometrial cancer study MSN
Published: May 31, 2026, 5:59 a.m.
60 Minutes Sports: "Friday Night Lights" Endometriosis (ZVkqq3fC7a) - Mshale
60 Minutes Sports: "Friday Night Lights" Endometriosis (ZVkqq3fC7a) Mshale
Published: May 31, 2026, 2:18 a.m.
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive
Published: May 30, 2026, 9:59 p.m.
Endometrial Cancer Survivors Face Harder Path to IVF Success - MedPage Today
Endometrial Cancer Survivors Face Harder Path to IVF Success MedPage Today
Published: May 30, 2026, 4:38 p.m.
18-year-old's openness about endometriosis leads to regional first, growing momentum - PembinaValleyOnline
18-year-old's openness about endometriosis leads to regional first, growing momentum PembinaValleyOnline
Published: May 30, 2026, 10:04 a.m.
"The disease took everything from me": This athlete opens up about her battle against endometriosis - MSN
"The disease took everything from me": This athlete opens up about her battle against endometriosis MSN
Published: May 30, 2026, 5:22 a.m.
Menstrual blood may help detect endometriosis without surgery new study reveals - TheHealthSite
Menstrual blood may help detect endometriosis without surgery new study reveals TheHealthSite
Published: May 30, 2026, 5:13 a.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor
Published: May 30, 2026, 4 a.m.
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical
Published: May 30, 2026, 2:16 a.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive
Published: May 30, 2026, 12:24 a.m.
Link copied to clipboard!